Literature DB >> 12537939

Biomaterials in urology.

Darren T Beiko1, Bodo E Knudsen, James D Watterson, John D Denstedt.   

Abstract

Biomaterials such as urethral catheters, urethral stents, and ureteral stents are commonly used in patients with urologic disorders. There are currently many different bulk materials and coatings available for the manufacture of urinary tract biomaterials; however, the ideal material has yet to be discovered. Any potential biomaterial must undergo rigorous physical and biocompatibility testing before commercialization and use in humans. Despite significant advances in basic science research involving biocompatibility issues and biofilm formation, infection and encrustation remain associated with the use of biomaterials in the urinary tract, and therefore, limit their long-term use. This review critically evaluates the literature published over the past 12 months, providing an update on the current status of naturally derived and synthetic polymeric biomaterial use in the urinary tract. We focus on urethral catheters, urethral stents, and ureteral stents. We discuss issues of biocompatibility and new approaches to biocompatibility testing, biomaterials currently available for use, new biomaterials and coatings, and novel ureteral stent designs. Finally, we discuss the future of biomaterial use in the urinary tract.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12537939     DOI: 10.1007/s11934-003-0057-4

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  27 in total

1.  Evaluation of the use of a biodegradable ureteral stent after retrograde endopyelotomy in a porcine model.

Authors:  Ephrem O Olweny; Jaime Landman; Cassio Andreoni; William Collyer; Kurt Kerbl; Mikhaila Onciu; Tero Välimaa; Ralph V Clayman
Journal:  J Urol       Date:  2002-05       Impact factor: 7.450

2.  Drug-eluting stents for the prevention of restenosis: in quest for the Holy Grail.

Authors:  Bonnie L Hiatt; Fumaiki Ikeno; Alan C Yeung; Andrew J Carter
Journal:  Catheter Cardiovasc Interv       Date:  2002-03       Impact factor: 2.692

3.  In vitro biocompatibility assessment of naturally derived and synthetic biomaterials using normal human urothelial cells.

Authors:  J L Pariente; B S Kim; A Atala
Journal:  J Biomed Mater Res       Date:  2001-04

4.  Clinical effectiveness of new stent design: randomized single-blind comparison of tail and double-pigtail stents.

Authors:  M D Dunn; A J Portis; S A Kahn; Y Yan; A L Shalhav; A M Elbahnasy; E Bercowsky; D M Hoenig; J S Wolf; E M McDougall; R V Clayman
Journal:  J Endourol       Date:  2000-03       Impact factor: 2.942

5.  Tail stent versus re-entry tube: a randomized comparison after percutaneous stone extraction.

Authors:  Evangelos N Liatsikos; David Hom; Caner Z Dinlenc; Rakesh Kapoor; Mihai Alexianu; Paulos Yohannes; Arthur D Smith
Journal:  Urology       Date:  2002-01       Impact factor: 2.649

6.  DNA sequencing and expression of the formyl coenzyme A transferase gene, frc, from Oxalobacter formigenes.

Authors:  H Sidhu; S D Ogden; H Y Lung; B G Luttge; A L Baetz; A B Peck
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

7.  Rabbit muscle and urethral in situ biocompatibility properties of the self-reinforced L-lactide-glycolic acid copolymer 80: 20 spiral stent.

Authors:  Susanna Laaksovirta; Marita Laurila; Taina Isotalo; Tero Välimaa; Teuvo L J Tammela; Pertti Törmälä; Martti Talja
Journal:  J Urol       Date:  2002-03       Impact factor: 7.450

8.  Heparin coating reduces encrustation of ureteral stents: a preliminary report.

Authors:  Claus R Riedl; Marc Witkowski; Eugen Plas; Heinz Pflueger
Journal:  Int J Antimicrob Agents       Date:  2002-06       Impact factor: 5.283

9.  Oxalate-degrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation.

Authors:  James D Watterson; Peter A Cadieux; Darren T Beiko; Anthony J Cook; Jeremy P Burton; Robert R Harbottle; Clarence Lee; Elaine Rowe; Harmeet Sidhu; Gregor Reid; John D Denstedt
Journal:  J Endourol       Date:  2003-06       Impact factor: 2.942

Review 10.  Use of prostatic stents for the treatment of benign prostatic hyperplasia in high-risk patients.

Authors:  J S Lam; M A Volpe; S A Kaplan
Journal:  Curr Urol Rep       Date:  2001-08       Impact factor: 2.862

View more
  2 in total

1.  New anti-infective coatings of medical implants.

Authors:  F D Matl; A Obermeier; S Repmann; W Friess; A Stemberger; K-D Kuehn
Journal:  Antimicrob Agents Chemother       Date:  2008-03-24       Impact factor: 5.191

Review 2.  Synthetic biomaterials for pelvic floor reconstruction.

Authors:  Matthew E Karlovsky; Leslie Kushner; Gopal H Badlani
Journal:  Curr Urol Rep       Date:  2005-09       Impact factor: 2.862

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.